<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35505000</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">2193-8229</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>11</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Infectious diseases and therapy</Title>
          <ISOAbbreviation>Infect Dis Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Legionnaires' Disease: Update on Diagnosis and Treatment.</ArticleTitle>
        <Pagination>
          <StartPage>973</StartPage>
          <EndPage>986</EndPage>
          <MedlinePgn>973-986</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40121-022-00635-7</ELocationID>
        <Abstract>
          <AbstractText>Legionellosis is the infection caused by bacteria of the genus Legionella, including a non-pneumonic influenza-like syndrome, and Legionnaires' disease is a more serious illness characterized by pneumonia. Legionellosis is becoming increasingly important as a public health problem throughout the world; although it is an underreported disease, studies have consistently documented a high incidence. In addition, health costs associated with the disease are high. Diagnosis of Legionnaires' disease is based mainly on the detection of Legionella pneumophila serogroup 1 antigen in urine. However, there have been advances in detection tests for patients with legionellosis. New methodologies show greater sensitivity and specificity, detect more species and serogroups of Legionella spp., and have the potential for use in epidemiological studies. Testing for Legionella spp. is recommended at hospital admission for severe community-acquired pneumonia, and antibiotics directed against Legionella spp. should be included early as empirical therapy. Inadequate or delayed antibiotic treatment in Legionella pneumonia has been associated with a worse prognosis. Either a fluoroquinolone (levofloxacin or moxifloxacin) or a macrolide (azithromycin preferred) is the recommended first-line therapy for Legionnaires' disease; however, little information is available regarding adverse events or complications, or about the duration of antibiotic therapy and its association with clinical outcomes. Most published studies evaluating antibiotic treatment for Legionnaires' disease are observational and consequently susceptible to bias and confounding. Well-designed studies are needed to assess the usefulness of diagnostic tests regarding clinical outcomes, as well as randomized trials comparing fluoroquinolones and macrolides or combination therapy that evaluate outcomes and adverse events.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Viasus</LastName>
            <ForeName>Diego</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Health Sciences, Universidad del Norte and Hospital Universidad del Norte, Barranquilla, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gaia</LastName>
            <ForeName>Valeria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>National Reference Center for Legionella, Institute of Laboratory Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>ESCMID Study Group for Legionella Infections (ESGLI), Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Manzur-Barbur</LastName>
            <ForeName>Carolina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Health Sciences, Universidad del Norte and Hospital Universidad del Norte, Barranquilla, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carratalà</LastName>
            <ForeName>Jordi</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0003-3209-2563</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Insitute (IDIBELL), Feixa Llarga s/n, Barcelona, Spain. jcarratala@bellvitgehospital.cat.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain. jcarratala@bellvitgehospital.cat.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC; CB21/13/00009), Instituto de Salud Carlos III, Madrid, Spain. jcarratala@bellvitgehospital.cat.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Infect Dis Ther</MedlineTA>
        <NlmUniqueID>101634499</NlmUniqueID>
        <ISSNLinking>2193-6382</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Diagnosis</Keyword>
        <Keyword MajorTopicYN="N">Legionella spp.</Keyword>
        <Keyword MajorTopicYN="N">Legionnaires’ disease</Keyword>
        <Keyword MajorTopicYN="N">Pneumonia</Keyword>
        <Keyword MajorTopicYN="N">Treatment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>23</Hour>
          <Minute>22</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35505000</ArticleId>
        <ArticleId IdType="pmc">PMC9124264</ArticleId>
        <ArticleId IdType="doi">10.1007/s40121-022-00635-7</ArticleId>
        <ArticleId IdType="pii">10.1007/s40121-022-00635-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Viasus D, Carratalà J.  Oxford textbook of medicine. 6. Oxford: Oxford University Press; 2020. Legionellosis and Legionnaires’ disease.</Citation>
        </Reference>
        <Reference>
          <Citation>Cunha BA, Burillo A, Bouza E. Legionnaires’ disease. Lancet. 2016;387:376–385. doi: 10.1016/S0140-6736(15)60078-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(15)60078-2</ArticleId>
            <ArticleId IdType="pubmed">26231463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fields BS, Benson RF, Besser RE. Legionella and Legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev. 2002;15:506–526. doi: 10.1128/CMR.15.3.506-526.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.15.3.506-526.2002</ArticleId>
            <ArticleId IdType="pmc">PMC118082</ArticleId>
            <ArticleId IdType="pubmed">12097254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priest PC, Slow S, Chambers ST, et al.  The burden of Legionnaires’ disease in New Zealand (LegiNZ): a national surveillance study. Lancet Infect Dis. 2019;19:770–777. doi: 10.1016/S1473-3099(19)30113-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(19)30113-6</ArticleId>
            <ArticleId IdType="pubmed">31196812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chambers ST, Slow S, Scott-Thomas A, Murdoch DR. Legionellosis caused by non-Legionella pneumophila species, with a focus on Legionella longbeachae. Microorganisms. 2021;9:291. doi: 10.3390/microorganisms9020291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/microorganisms9020291</ArticleId>
            <ArticleId IdType="pmc">PMC7910863</ArticleId>
            <ArticleId IdType="pubmed">33572638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chauhan D, Shames SR. Pathogenicity and virulence of Legionella: intracellular replication and host response. Virulence. 2021;12(1):1122–1144. doi: 10.1080/21505594.2021.1903199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21505594.2021.1903199</ArticleId>
            <ArticleId IdType="pmc">PMC8043192</ArticleId>
            <ArticleId IdType="pubmed">33843434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burillo A, Pedro-Botet ML, Bouza E. Microbiology and epidemiology of Legionnaires’ disease. Infect Dis Clin N Am. 2017;31:7–27. doi: 10.1016/j.idc.2016.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idc.2016.10.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Viasus D, Di Yacovo S, Garcia-Vidal C, et al.  Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore) 2013;92:51–60. doi: 10.1097/MD.0b013e31827f6104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e31827f6104</ArticleId>
            <ArticleId IdType="pmc">PMC5348137</ArticleId>
            <ArticleId IdType="pubmed">23266795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allgaier J, Lagu T, Haessler S, et al.  Risk factors, management, and outcomes of Legionella pneumonia in a large, Nationally representative sample. Chest. 2021;159:1782–1792. doi: 10.1016/j.chest.2020.12.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2020.12.013</ArticleId>
            <ArticleId IdType="pubmed">33352192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gramegna A, Sotgiu G, Di Pasquale M, GLIMP Study Group et al.  Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective. BMC Infect Dis. 2018;18:677. doi: 10.1186/s12879-018-3565-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-018-3565-z</ArticleId>
            <ArticleId IdType="pmc">PMC6299604</ArticleId>
            <ArticleId IdType="pubmed">30563504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arancibia F, Cortes CP, Valdés M, et al.  Importance of Legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago, Chile. Chest. 2014;145:290–296. doi: 10.1378/chest.13-0162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.13-0162</ArticleId>
            <ArticleId IdType="pubmed">23764871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellew S, Grijalva CG, Williams DJ, et al.  Pneumococcal and Legionella urinary antigen tests in community-acquired pneumonia: prospective evaluation of indications for testing. Clin Infect Dis. 2019;68:2026–2033. doi: 10.1093/cid/ciy826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciy826</ArticleId>
            <ArticleId IdType="pmc">PMC7182343</ArticleId>
            <ArticleId IdType="pubmed">30265290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farnham A, Alleyne L, Cimini D, Balter S. Legionnaires; disease incidence and risk factors, New York, New York, USA, 2002–2011. Emerg Infect Dis. 2014;20(11):1795–1802. doi: 10.3201/eid2011.131872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2011.131872</ArticleId>
            <ArticleId IdType="pmc">PMC4214295</ArticleId>
            <ArticleId IdType="pubmed">25513657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrea L, Dicpinigaitis PV, Fazzari MJ, Kapoor S. Legionella pneumonia in the ICU: a tertiary care center experience over 10 years. Crit Care Explor. 2021;3(8):e0508. doi: 10.1097/CCE.0000000000000508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CCE.0000000000000508</ArticleId>
            <ArticleId IdType="pmc">PMC8357248</ArticleId>
            <ArticleId IdType="pubmed">34396145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Regueiro-Mira MV, Pita-Fernández S, Pértega-Díaz S, López-Calviño B, Seoane-Pillado T, Fernández-Albalat-Ruiz M. Prognostic factors in adult patients hospitalized for pneumonia caused by Legionella pneumophila. Rev Chilena Infectol. 2015;32(4):435–444. doi: 10.4067/S0716-10182015000500010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4067/S0716-10182015000500010</ArticleId>
            <ArticleId IdType="pubmed">26436788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wingfield T, Rowell S, Peel A, Puli D, Guleri A, Sharma R. Legionella pneumonia cases over a five-year period: a descriptive, retrospective study of outcomes in a UK district hospital. Clin Med (Lond) 2013;13(2):152–159. doi: 10.7861/clinmedicine.13-2-152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7861/clinmedicine.13-2-152</ArticleId>
            <ArticleId IdType="pmc">PMC4952631</ArticleId>
            <ArticleId IdType="pubmed">23681863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gershengorn HB, Keene A, Dzierba AL, Wunsch H. The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia. Clin Infect Dis. 2015;60(11):e66–79. doi: 10.1093/cid/civ157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/civ157</ArticleId>
            <ArticleId IdType="pubmed">25722195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hung TL, Li MC, Wang LR, Liu CC, Li CW, Chen PL, Syue LS, Lee NY, Ko WC. Legionnaires’ disease at a medical center in southern Taiwan. J Microbiol Immunol Infect. 2018;51(3):352–358. doi: 10.1016/j.jmii.2016.08.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmii.2016.08.006</ArticleId>
            <ArticleId IdType="pubmed">28094205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dagan A, Epstein D, Mahagneh A, Nashashibi J, Geffen Y, Neuberger A, Miller A. Community-acquired versus nosocomial Legionella pneumonia: factors associated with Legionella-related mortality. Eur J Clin Microbiol Infect Dis. 2021;40(7):1419–1426. doi: 10.1007/s10096-021-04172-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-021-04172-y</ArticleId>
            <ArticleId IdType="pubmed">33527200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sivagnanam S, Podczervinski S, Butler-Wu SM, Hawkins V, Stednick Z, Helbert LA, Glover WA, Whimbey E, Duchin J, Cheng GS, Pergam SA. Legionnaires' disease in transplant recipients: a 15-year retrospective study in a tertiary referral center. Transpl Infect Dis. 2017;19(5)</Citation>
        </Reference>
        <Reference>
          <Citation>Cooley LA, Pondo T, Francois Watkins LK, Shah P, Schrag S, Active Bacterial Core Surveillance Program of the Emerging Infections Program Network  Population-based assessment of clinical risk factors for Legionnaires’ disease. Clin Infect Dis. 2020;70:2428–2431. doi: 10.1093/cid/ciz771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciz771</ArticleId>
            <ArticleId IdType="pmc">PMC9067372</ArticleId>
            <ArticleId IdType="pubmed">31617567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mudali G, Kilgore PE, Salim A, McElmurry SP, Zervos M. Trends in Legionnaires’ disease-associated hospitalizations, United States, 2006–2010. Open Forum Infect Dis. 2020;7:ofaa296. doi: 10.1093/ofid/ofaa296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ofid/ofaa296</ArticleId>
            <ArticleId IdType="pmc">PMC7443102</ArticleId>
            <ArticleId IdType="pubmed">32855985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cassell K, Gacek P, Rabatsky-Ehr T, Petit S, Cartter M, Weinberger DM. Estimating the true burden of Legionnaires’ disease. Am J Epidemiol. 2019;188(9):1686–1694. doi: 10.1093/aje/kwz142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/aje/kwz142</ArticleId>
            <ArticleId IdType="pubmed">31225857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walker JT. The influence of climate change on waterborne disease and Legionella: a review. Perspect Public Health. 2018;138:282–286. doi: 10.1177/1757913918791198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1757913918791198</ArticleId>
            <ArticleId IdType="pubmed">30156484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neil K, Berkelman R. Increasing incidence of Legionellosis in the United States, 1990–2005: changing epidemiologic trends. Clin Infect Dis. 2008;47:591–599. doi: 10.1086/590557.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/590557</ArticleId>
            <ArticleId IdType="pubmed">18665818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Legionnaires Disease Surveillance Summary Report, United States, 2016–2017. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC. https://www.cdc.gov/legionella/health-depts/surv-reporting/2016-17-surv-report-508.pdf. Accessed 1 Feb 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>ECDC. Legionnaires’ disease annual epidemiological report for 2019. https://www.ecdc.europa.eu/en/publications-data/legionnaires-disease-annual-epidemiological-report-2019. Accessed 1 Feb 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>Leung YH, Lam CK, Cheung YY, Chan CW, Chuang SK. Epidemiology of Legionnaires’ disease, Hong Kong, China, 2005–2015. Emerg Infect Dis. 2020;26:1695–1702. doi: 10.3201/eid2608.191244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2608.191244</ArticleId>
            <ArticleId IdType="pmc">PMC7392469</ArticleId>
            <ArticleId IdType="pubmed">32687025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fastl C, Devleesschauwer B, van Cauteren D, et al.  The burden of Legionnaires’ disease in Belgium, 2013 to 2017. Arch Public Health. 2020;78:92. doi: 10.1186/s13690-020-00470-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13690-020-00470-7</ArticleId>
            <ArticleId IdType="pmc">PMC7539445</ArticleId>
            <ArticleId IdType="pubmed">33042538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collier SA, Deng L, Adam EA, et al.  Estimate of burden and direct healthcare cost of infectious waterborne disease in the United States. Emerg Infect Dis. 2021;27:140–149. doi: 10.3201/eid2701.190676.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2701.190676</ArticleId>
            <ArticleId IdType="pmc">PMC7774540</ArticleId>
            <ArticleId IdType="pubmed">33350905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baker-Goering M, Roy K, Edens C, Collier S. Economic burden of Legionnaires’ disease, United States, 2014. Emerg Infect Dis. 2021;27:255–257. doi: 10.3201/eid2701.191198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2701.191198</ArticleId>
            <ArticleId IdType="pmc">PMC7774564</ArticleId>
            <ArticleId IdType="pubmed">33350911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ECDC. European Centre for Disease Prevention and Control. Annual Epidemiological report for 2019. Legionnaires’ disease. https://www.ecdc.europa.eu/sites/default/files/documents/AER-legionnaires-2019.pdf2021. Accessed 1 Feb 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>Kenagy E, Priest PC, Cameron CM, et al.  Risk factors for Legionella longbeachae Legionnaires’ disease. N Z Emerg Infect Dis. 2017;23(7):1148–1154.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization  . Legionella and the prevention of Legionellosis. WHO; 2007. </Citation>
        </Reference>
        <Reference>
          <Citation>Pierre DM, Baron J, Yu VL, Stout JE. Diagnostic testing for Legionnaires’ disease. Ann Clin Microbiol Antimicrob. 2017;16(1):59. doi: 10.1186/s12941-017-0229-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12941-017-0229-6</ArticleId>
            <ArticleId IdType="pmc">PMC5576257</ArticleId>
            <ArticleId IdType="pubmed">28851372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Essig A, von Baum H, Gonser T, Haerter G, Luck C. Microbiological diagnosis and molecular typing of Legionella strains during an outbreak of legionellosis in Southern Germany. Int J Med Microbiol. 2016;306(2):109–114. doi: 10.1016/j.ijmm.2016.01.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2016.01.001</ArticleId>
            <ArticleId IdType="pubmed">26868659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mercante JW, Winchell JM. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev. 2015;28(1):95–133. doi: 10.1128/CMR.00029-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00029-14</ArticleId>
            <ArticleId IdType="pmc">PMC4284297</ArticleId>
            <ArticleId IdType="pubmed">25567224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, Macfarlane JT, Read RC, Roberts HJ, Levy ML, Wani M, Woodhead MA, Pneumonia Guidelines Committee of the BTS Standards of Care Committee  BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–55. doi: 10.1136/thx.2009.121434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thx.2009.121434</ArticleId>
            <ArticleId IdType="pubmed">19783532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birtles RJ, Harrison TG, Samuel D, Taylor AG. Evaluation of urinary antigen ELISA for diagnosing Legionella pneumophila serogroup 1 infection. J Clin Pathol. 1990;43(8):685–690. doi: 10.1136/jcp.43.8.685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.43.8.685</ArticleId>
            <ArticleId IdType="pmc">PMC502655</ArticleId>
            <ArticleId IdType="pubmed">2401738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams A, Lever MS. Characterisation of Legionella pneumophila antigen in urine of guinea pigs and humans with Legionnaires’ disease. J Infect. 1995;30(1):13–16. doi: 10.1016/S0163-4453(95)92691-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0163-4453(95)92691-7</ArticleId>
            <ArticleId IdType="pubmed">7751659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawasaki T, Nakagawa N, Murata M, et al.  Diagnostic accuracy of urinary antigen tests for legionellosis: a systematic review and meta-analysis. Respir Investig. 2021;60(2):205–214. doi: 10.1016/j.resinv.2021.11.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.resinv.2021.11.011</ArticleId>
            <ArticleId IdType="pubmed">34972680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menéndez R, Torres A, Aspa J, Capelastegui A, Prat C, de Castro FR, Sociedad Española de Neumología y Cirugía Torácica  Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR) Arch Bronconeumol. 2010;46(10):543–558. doi: 10.1016/j.arbres.2010.06.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.arbres.2010.06.014</ArticleId>
            <ArticleId IdType="pubmed">20832928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Losier A, Dela Cruz CS. New testing guidelines for community-acquired pneumonia. Curr Opin Infect Dis. 2022;35(2):128–132. doi: 10.1097/QCO.0000000000000824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QCO.0000000000000824</ArticleId>
            <ArticleId IdType="pubmed">35245248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rota MC, Fontana S, Montano-Remacha C, et al.  Legionnaires’ disease pseudoepidemic due to falsely positive urine antigen test results. J Clin Microbiol. 2014;52(6):2279–2280. doi: 10.1128/JCM.00493-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00493-14</ArticleId>
            <ArticleId IdType="pmc">PMC4042736</ArticleId>
            <ArticleId IdType="pubmed">24719437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Como J, Moffa MA, Bhanot N, et al.  Potential false-positive urine Legionella enzyme immunoassay test results. Eur J Clin Microbiol Infect Dis. 2019;38(7):1377–1382. doi: 10.1007/s10096-019-03575-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-019-03575-2</ArticleId>
            <ArticleId IdType="pubmed">31119574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doskeland SO, Berdal BP. Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions. J Clin Microbiol. 1980;11(4):380–384. doi: 10.1128/jcm.11.4.380-384.1980.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jcm.11.4.380-384.1980</ArticleId>
            <ArticleId IdType="pmc">PMC273408</ArticleId>
            <ArticleId IdType="pubmed">7372801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White A, Kohler RB, Wheat LJ, et al.  Rapid diagnosis of Legionnaires’ disease. Trans Am Clin Climatol Assoc. 1982;93:50–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2279536</ArticleId>
            <ArticleId IdType="pubmed">7048694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beraud L, Gervasoni K, Freydiere AM, et al.  Comparison of Sofia Legionella FIA and BinaxNOW(R) Legionella urinary antigen card in two national reference centers. Eur J Clin Microbiol Infect Dis. 2015;34(9):1803–1807. doi: 10.1007/s10096-015-2415-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-015-2415-9</ArticleId>
            <ArticleId IdType="pmc">PMC4545177</ArticleId>
            <ArticleId IdType="pubmed">26092030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pontoizeau C, Dangers L, Jarlier V, et al.  Ruling out false-positive urinary Legionella pneumophila serogroup 1 and Streptococcus pneumoniae antigen test results by heating urine. J Clin Microbiol. 2014;52(12):4347–4349. doi: 10.1128/JCM.01916-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01916-14</ArticleId>
            <ArticleId IdType="pmc">PMC4313311</ArticleId>
            <ArticleId IdType="pubmed">25253788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higa F, Fujita J, Koide M, Haranaga S, Tateyama M. Clinical features of two cases of Legionnaires’ disease with persistence of Legionella urinary antigen excretion. Intern Med. 2008;47(3):173–178. doi: 10.2169/internalmedicine.47.0522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.47.0522</ArticleId>
            <ArticleId IdType="pubmed">18239328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sopena N, Sabria M, Pedro-Botet ML, Reynaga E, Garcia-Nunez M, Dominguez J, et al.  Factors related to persistence of Legionella urinary antigen excretion in patients with Legionnaires’ disease. Eur J Clin Microbiol Infect Dis. 2002;21(12):845–848. doi: 10.1007/s10096-002-0839-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-002-0839-5</ArticleId>
            <ArticleId IdType="pubmed">12525918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Helbig JH, Uldum SA, Bernander S, et al.  Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease. J Clin Microbiol. 2003;41(2):838–840. doi: 10.1128/JCM.41.2.838-840.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.41.2.838-840.2003</ArticleId>
            <ArticleId IdType="pmc">PMC149701</ArticleId>
            <ArticleId IdType="pubmed">12574296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Viasus D, Calatayud L, McBrown MV, Ardanuy C, Carratala J. Urinary antigen testing in community-acquired pneumonia in adults: an update. Expert Rev Anti Infect Ther. 2019;17(2):107–115. doi: 10.1080/14787210.2019.1565994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14787210.2019.1565994</ArticleId>
            <ArticleId IdType="pubmed">30618315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muyldermans A, Descheemaeker P, Boel A, et al.  What is the risk of missing legionellosis relying on urinary antigen testing solely? A retrospective Belgian multicenter study. Eur J Clin Microbiol Infect Dis. 2020;39(4):729–734. doi: 10.1007/s10096-019-03785-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-019-03785-8</ArticleId>
            <ArticleId IdType="pubmed">31838606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaccaro L, Izquierdo F, Magnet A, et al.  First case of Legionnaires’ disease caused by Legionella anisa in Spain and the limitations on the diagnosis of Legionella non-pneumophila infections. PLoS ONE. 2016;11(7):e0159726. doi: 10.1371/journal.pone.0159726.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0159726</ArticleId>
            <ArticleId IdType="pmc">PMC4956277</ArticleId>
            <ArticleId IdType="pubmed">27442238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okada C, Kura F, Wada A, Inagawa H, Lee GH, Matsushita H. Cross-reactivity and sensitivity of two Legionella urinary antigen kits, Biotest EIA and Binax NOW, to extracted antigens from various serogroups of L. pneumophila and other Legionella species. Microbiol Immunol. 2002;46(1):51–54. doi: 10.1111/j.1348-0421.2002.tb02676.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1348-0421.2002.tb02676.x</ArticleId>
            <ArticleId IdType="pubmed">11911189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito A, Yamamoto Y, Ishii Y, Okazaki A, Ishiura Y, Kawagishi Y, et al.  Evaluation of a novel urinary antigen test kit for diagnosing Legionella pneumonia. Int J Infect Dis. 2020;103:42–47. doi: 10.1016/j.ijid.2020.10.106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijid.2020.10.106</ArticleId>
            <ArticleId IdType="pubmed">33176204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamura A, Fukuda S, Kusuki M, Watari H, Shimura S, Kimura K, et al.  Evaluation of five Legionella urinary antigen detection kits including new Ribotest Legionella for simultaneous detection of ribosomal protein L7/L12. J Infect Chemother. 2021;27(10):1533–1535. doi: 10.1016/j.jiac.2021.05.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiac.2021.05.019</ArticleId>
            <ArticleId IdType="pubmed">34088604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robert S, Lhommet C, Brun CL, et al.  Diagnostic performance of multiplex PCR on pulmonary samples versus nasopharyngeal aspirates in community-acquired severe lower respiratory tract infections. J Clin Virol. 2018;108:1–5. doi: 10.1016/j.jcv.2018.08.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcv.2018.08.001</ArticleId>
            <ArticleId IdType="pmc">PMC7185397</ArticleId>
            <ArticleId IdType="pubmed">30195090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diederen BM, de Jong CM, Kluytmans JA, van der Zee A, Peeters MF. Detection and quantification of Legionella pneumophila DNA in serum: case reports and review of the literature. J Med Microbiol. 2006;55(Pt 5):639–642. doi: 10.1099/jmm.0.46453-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.46453-0</ArticleId>
            <ArticleId IdType="pubmed">16585654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diederen BM, de Jong CM, Marmouk F, Kluytmans JA, Peeters MF, Van der Zee A. Evaluation of real-time PCR for the early detection of Legionella pneumophila DNA in serum samples. J Med Microbiol. 2007;56(Pt 1):94–101. doi: 10.1099/jmm.0.46714-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.46714-0</ArticleId>
            <ArticleId IdType="pubmed">17172523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsiota-Bernard P, Waser S, Vrioni G. Detection of Legionella pneumophila DNA in urine and serum samples from patients with pneumonia. Clin Microbiol Infect. 2000;6(4):223–225. doi: 10.1046/j.1469-0691.2000.00041-2.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1469-0691.2000.00041-2.x</ArticleId>
            <ArticleId IdType="pubmed">11168113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murdoch DR, Walford EJ, Jennings LC, et al.  Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia. Clin Infect Dis. 1996;23(3):475–480. doi: 10.1093/clinids/23.3.475.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/clinids/23.3.475</ArticleId>
            <ArticleId IdType="pubmed">8879767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mentasti M, Kese D, Echahidi F, et al.  Design and validation of a qPCR assay for accurate detection and initial serogrouping of Legionella pneumophila in clinical specimens by the ESCMID Study Group for Legionella Infections (ESGLI) Eur J Clin Microbiol Infect Dis. 2015;34(7):1387–1393. doi: 10.1007/s10096-015-2363-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-015-2363-4</ArticleId>
            <ArticleId IdType="pubmed">25851812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benitez AJ, Winchell JM. Clinical application of a multiplex real-time PCR assay for simultaneous detection of Legionella species, Legionella pneumophila, and Legionella pneumophila serogroup 1. J Clin Microbiol. 2013;51(1):348–351. doi: 10.1128/JCM.02510-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02510-12</ArticleId>
            <ArticleId IdType="pmc">PMC3536254</ArticleId>
            <ArticleId IdType="pubmed">23135949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Merault N, Rusniok C, Jarraud S, et al.  Specific real-time PCR for simultaneous detection and identification of Legionella pneumophila serogroup 1 in water and clinical samples. Appl Environ Microbiol. 2011;77(5):1708–1717. doi: 10.1128/AEM.02261-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.02261-10</ArticleId>
            <ArticleId IdType="pmc">PMC3067292</ArticleId>
            <ArticleId IdType="pubmed">21193672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginevra C, Chastang J, David S, et al.  A real-time PCR for specific detection of the Legionella pneumophila serogroup 1 ST1 complex. Clin Microbiol Infect. 2020;26(4):514 e1–e6. doi: 10.1016/j.cmi.2019.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2019.09.002</ArticleId>
            <ArticleId IdType="pubmed">31525518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mentasti M, Cassier P, David S, et al.  Rapid detection and evolutionary analysis of Legionella pneumophila serogroup 1 sequence type 47. Clin Microbiol Infect. 2017;23(4):264 e1–e9. doi: 10.1016/j.cmi.2016.11.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2016.11.019</ArticleId>
            <ArticleId IdType="pubmed">27915212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avni T, Bieber A, Green H, Steinmetz T, Leibovici L, Paul M. Diagnostic accuracy of PCR alone and compared to urinary antigen testing for detection of Legionella spp.: a systematic review. J Clin Microbiol. 2016;54(2):401–11. doi: 10.1128/JCM.02675-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02675-15</ArticleId>
            <ArticleId IdType="pmc">PMC4733173</ArticleId>
            <ArticleId IdType="pubmed">26659202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ricci ML, Grottola A, Fregni Serpini G, et al.  Improvement of Legionnaires' disease diagnosis using real-time PCR assay: a retrospective analysis, Italy, 2010 to 2015. Euro Surveill. 2018;23(50):1800032. doi: 10.2807/1560-7917.ES.2018.23.50.1800032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.50.1800032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothe K, Spinner CD, Panning M, et al.  Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ) Infection. 2021;49(6):1299–1306. doi: 10.1007/s15010-021-01720-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s15010-021-01720-8</ArticleId>
            <ArticleId IdType="pmc">PMC8536912</ArticleId>
            <ArticleId IdType="pubmed">34687426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang Y, Ma Y, Miao Q, et al.  Arthritis caused by Legionella micdadei and Staphylococcus aureus: metagenomic next-generation sequencing provides a rapid and accurate access to diagnosis and surveillance. Ann Transl Med. 2019;7(20):589. doi: 10.21037/atm.2019.09.81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/atm.2019.09.81</ArticleId>
            <ArticleId IdType="pmc">PMC6861802</ArticleId>
            <ArticleId IdType="pubmed">31807570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Dai Y, et al.  Case report: metagenomic next-generation sequencing in diagnosis of Legionella pneumophila pneumonia in a patient after umbilical cord blood stem cell transplantation. Front Med (Lausanne). 2021;8:643473. doi: 10.3389/fmed.2021.643473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmed.2021.643473</ArticleId>
            <ArticleId IdType="pmc">PMC8232522</ArticleId>
            <ArticleId IdType="pubmed">34179036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yue R, Wu X, Li T, Chang L, Huang X, Pan L. Early detection of Legionella pneumophila and Aspergillus by mNGS in a critically ill patient with Legionella Pneumonia after extracorporeal membrane oxygenation treatment: case report and literature review. Front Med (Lausanne). 2021;8:686512. doi: 10.3389/fmed.2021.686512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmed.2021.686512</ArticleId>
            <ArticleId IdType="pmc">PMC8277993</ArticleId>
            <ArticleId IdType="pubmed">34277662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis. 1996;15:286–290. doi: 10.1007/BF01695659.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF01695659</ArticleId>
            <ArticleId IdType="pubmed">8781878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gacouin A, Le Tulzo Y, Lavoue S, et al.  Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Med. 2002;28:686–691. doi: 10.1007/s00134-002-1304-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00134-002-1304-8</ArticleId>
            <ArticleId IdType="pubmed">12107671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Falcone M, Russo A, Tiseo G, Cesaretti M, Guarracino F, Menichetti F. Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy. Infection. 2021;49:321–325. doi: 10.1007/s15010-020-01565-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s15010-020-01565-7</ArticleId>
            <ArticleId IdType="pmc">PMC7734452</ArticleId>
            <ArticleId IdType="pubmed">33315182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chidiac C, Che D, Pires-Cronenberger S, French Legionnaires’ Disease Study Group et al.  Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J. 2012;39:963–70. doi: 10.1183/09031936.00076911.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00076911</ArticleId>
            <ArticleId IdType="pubmed">22005914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodhead M, Blasi F, Ewig S, Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases et al.  Guidelines for the management of adult lower respiratory tract infections—full version. Clin Microbiol Infect. 2011;17(Suppl 6):E1–59. doi: 10.1111/j.1469-0691.2011.03672.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2011.03672.x</ArticleId>
            <ArticleId IdType="pmc">PMC7128977</ArticleId>
            <ArticleId IdType="pubmed">21951385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metlay JP, Waterer GW, Long AC, et al.  Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45–e67. doi: 10.1164/rccm.201908-1581ST.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201908-1581ST</ArticleId>
            <ArticleId IdType="pmc">PMC6812437</ArticleId>
            <ArticleId IdType="pubmed">31573350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jasper AS, Musuuza JS, Tischendorf JS, et al.  Are fluoroquinolones or macrolides better for treating Legionella Pneumonia? A systematic review and meta-analysis. Clin Infect Dis. 2021;72:1979–1989. doi: 10.1093/cid/ciaa441.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciaa441</ArticleId>
            <ArticleId IdType="pmc">PMC8315122</ArticleId>
            <ArticleId IdType="pubmed">32296816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato H, Hagihara M, Asai N, et al.  Meta-analysis of fluoroquinolones versus macrolides for treatment of Legionella pneumonia. J Infect Chemother. 2021;27:424–433. doi: 10.1016/j.jiac.2020.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiac.2020.10.002</ArticleId>
            <ArticleId IdType="pubmed">33268272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torres A, Cillóniz C. Are macrolides as effective as fluoroquinolones in Legionella Pneumonia? Yes, but. Clin Infect Dis. 2021;72:1990–1991. doi: 10.1093/cid/ciaa442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciaa442</ArticleId>
            <ArticleId IdType="pubmed">32296825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cocuzza CE, Martinelli M, Perdoni F, Giubbi C, Vinetti MEA, Calaresu E, Frugoni S, Scaturro M, Ricci ML, Musumeci R. Antibiotic susceptibility of environmental Legionella pneumophila strains isolated in Northern Italy. Int J Environ Res Public Health. 2021;18(17):9352. doi: 10.3390/ijerph18179352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijerph18179352</ArticleId>
            <ArticleId IdType="pmc">PMC8431511</ArticleId>
            <ArticleId IdType="pubmed">34501942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edelstein PH. Azithromycin phenotypic versus clinical resistance. Antimicrob Agents Chemother. 2019;64(1):e01986–e2019. doi: 10.1128/AAC.01986-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01986-19</ArticleId>
            <ArticleId IdType="pmc">PMC7187571</ArticleId>
            <ArticleId IdType="pubmed">31862771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Natås OB, Brekken AL, Bernhoff E, Hetland MAK, Löhr IH, Lindemann PC. Susceptibility of Legionella pneumophila to antimicrobial agents and the presence of the efflux pump LpeAB. J Antimicrob Chemother. 2019;74(6):1545–1550. doi: 10.1093/jac/dkz081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkz081</ArticleId>
            <ArticleId IdType="pubmed">30815687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin SJ, Pendland SL, Chen C, Schreckenberger P, Danziger LH. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella. Antimicrob Agents Chemother. 1996;40:1419–1421. doi: 10.1128/AAC.40.6.1419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.40.6.1419</ArticleId>
            <ArticleId IdType="pmc">PMC163342</ArticleId>
            <ArticleId IdType="pubmed">8726012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baltch AL, Smith RP, Ritz W. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila. Antimicrob Agents Chemother. 1995;39:1661–1666. doi: 10.1128/AAC.39.8.1661.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.39.8.1661</ArticleId>
            <ArticleId IdType="pmc">PMC162803</ArticleId>
            <ArticleId IdType="pubmed">7486896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Descours G, Ginevra C, Ader F, et al.  Rifampicin-macrolide synergy against Legionella pneumophila serogroup 1 in human macrophages using a quantitative real-time PCR assay. Int J Antimicrob Agents. 2011;38:188–189. doi: 10.1016/j.ijantimicag.2011.05.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2011.05.001</ArticleId>
            <ArticleId IdType="pubmed">21641188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin SJ, Pendland SL, Chen C, Schreckenberger PC, Danziger LH. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. Diagn Microbiol Infect Dis. 1997;29:167–71. doi: 10.1016/S0732-8893(97)81806-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0732-8893(97)81806-8</ArticleId>
            <ArticleId IdType="pubmed">9401809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varner TR, Bookstaver PB, Rudisill CN, Albrecht H. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia. Ann Pharmacother. 2011;45:967–976. doi: 10.1345/aph.1Q074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1345/aph.1Q074</ArticleId>
            <ArticleId IdType="pubmed">21775694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grau S, Antonio JM, Ribes E, Salvadó M, Garcés JM, Garau J. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia. Int J Antimicrob Agents. 2006;28:249–252. doi: 10.1016/j.ijantimicag.2006.03.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2006.03.029</ArticleId>
            <ArticleId IdType="pubmed">16870401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blázquez-Garrido RM, Espinosa-Parra FJ, Alemany-Francés L, et al.  Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis. 2005;40:800–806. doi: 10.1086/428049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/428049</ArticleId>
            <ArticleId IdType="pubmed">15736011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedro-Botet ML, García-Cruz A, Tural C, et al.  Severe Legionnaires’ disease successfully treated with levofloxacin and azithromycin. J Chemother. 2006;18:559–561. doi: 10.1179/joc.2006.18.5.559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1179/joc.2006.18.5.559</ArticleId>
            <ArticleId IdType="pubmed">17127236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trübel HK, Meyer HG, Jahn B, Knuf M, Kamin W, Huth RG. Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child. Scand J Infect Dis. 2002;34:219–221. doi: 10.1080/00365540110077317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00365540110077317</ArticleId>
            <ArticleId IdType="pubmed">12030402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamura S, Yanagihara K, Izumikawa K, et al.  The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila. J Infect. 2009;59:222–224. doi: 10.1016/j.jinf.2009.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2009.06.008</ArticleId>
            <ArticleId IdType="pubmed">19592113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lan SH, Lai CC, Chang SP, Lu LC, Hung SH, Lin WT. Five-day antibiotic treatment for community-acquired bacterial pneumonia: a systematic review and meta-analysis of randomized controlled trials. J Global Antimicrob Resist. 2020;23:94–99. doi: 10.1016/j.jgar.2020.08.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jgar.2020.08.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tansarli GS, Mylonakis E. Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrob Agents Chemother. 2018;62:e00635–e718. doi: 10.1128/AAC.00635-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00635-18</ArticleId>
            <ArticleId IdType="pmc">PMC6125522</ArticleId>
            <ArticleId IdType="pubmed">29987137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, Grammatikos AP, Athanassa Z, Falagas ME. Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs. 2008;68:1841–1854. doi: 10.2165/00003495-200868130-00004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00003495-200868130-00004</ArticleId>
            <ArticleId IdType="pubmed">18729535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>el Moussaoui R, de Borgie CA, van den Broek P, et al.  Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ. 2006;332:1355. doi: 10.1136/bmj.332.7554.1355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.332.7554.1355</ArticleId>
            <ArticleId IdType="pmc">PMC1479094</ArticleId>
            <ArticleId IdType="pubmed">16763247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siegel RE, Alicea M, Lee A, Blaiklock R. Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study. Am J Ther. 1999;6:217–222. doi: 10.1097/00045391-199907000-00007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00045391-199907000-00007</ArticleId>
            <ArticleId IdType="pubmed">11329100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uranga A, España PP, Bilbao A, et al.  Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. 2016;176:1257–1265. doi: 10.1001/jamainternmed.2016.3633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamainternmed.2016.3633</ArticleId>
            <ArticleId IdType="pubmed">27455166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuzman I, Soldo I, Schönwald S, Culig J. Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. Scand J Infect Dis. 1995;27:503–505. doi: 10.3109/00365549509047054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/00365549509047054</ArticleId>
            <ArticleId IdType="pubmed">8588143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amsden GW. Treatment of Legionnaires’ disease. Drugs. 2005;65:605–614. doi: 10.2165/00003495-200565050-00003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00003495-200565050-00003</ArticleId>
            <ArticleId IdType="pubmed">15748096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chahin A, Opal SM. Severe pneumonia caused by Legionella pneumophila: differential diagnosis and therapeutic considerations. Infect Dis Clin N Am. 2017;31:111–121. doi: 10.1016/j.idc.2016.10.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idc.2016.10.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lanternier F, Ader F, Pilmis B, Catherinot E, Jarraud S, Lortholary O. Legionnaires’ disease in compromised hosts. Infect Dis Clin N Am. 2017;31:123–135. doi: 10.1016/j.idc.2016.10.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idc.2016.10.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agence française de sécurité sanitaire des produits de santé. Traitement antibiotique de la légionellose chez l’adulte. https://www.infectiologie.com/UserFiles/File/medias/_documents/consensus/2011-afssaps-MAP-legionellose.pdf. Accessed 1 Feb 2022.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
